Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $290.41 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $190.96 | 2 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $99.45 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $190.96 | 2 | AstraZeneca Pharmaceuticals LP ($190.96) |
| 2017 | $99.45 | 2 | Merck Sharp & Dohme Corporation ($99.45) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $86.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $104.83 | General |
| Category: Oncology | ||||||
| 10/20/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $82.74 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,025 | 1,970 | $468,198 | $54,009 |
| 2022 | 17 | 1,958 | 3,776 | $899,977 | $110,087 |
| 2021 | 17 | 1,842 | 3,893 | $930,696 | $117,829 |
| 2020 | 16 | 1,334 | 2,610 | $623,884 | $80,974 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 268 | 548 | $135,356 | $15,225 | 11.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 151 | 338 | $83,363 | $8,871 | 10.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 93 | 374 | $78,914 | $7,830 | 9.9% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 66 | 79 | $21,691 | $4,081 | 18.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 110 | 137 | $28,907 | $3,561 | 12.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 100 | 117 | $30,420 | $2,381 | 7.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 27 | 33 | $15,147 | $1,992 | 13.2% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2023 | 15 | 17 | $11,168 | $1,862 | 16.7% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 27 | 58 | $17,632 | $1,835 | 10.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 37 | 45 | $9,390 | $1,187 | 12.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 23 | 54 | $6,102 | $1,025 | 16.8% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2023 | 15 | 21 | $5,334 | $1,007 | 18.9% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 13 | 19 | $4,066 | $891.73 | 21.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 17 | 39 | $7,807 | $834.35 | 10.7% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2023 | 17 | 21 | $3,570 | $564.26 | 15.8% |
| 88177 | Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | Facility | 2023 | 12 | 31 | $5,270 | $508.82 | 9.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 16 | 21 | $1,218 | $196.43 | 16.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 18 | 18 | $2,844 | $154.26 | 5.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 436 | 999 | $246,753 | $28,706 | 11.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 305 | 654 | $161,538 | $18,516 | 11.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 129 | 459 | $96,849 | $9,996 | 10.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 201 | 283 | $59,713 | $7,589 | 12.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 67 | 114 | $52,326 | $7,282 | 13.9% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2022 | 89 | 121 | $30,734 | $6,488 | 21.1% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 174 | 219 | $56,940 | $4,676 | 8.2% |
About Dr. Rujuta Kanhere, M.D
Dr. Rujuta Kanhere, M.D is a Anatomic Pathology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386858140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rujuta Kanhere, M.D has received a total of $290.41 in payments from pharmaceutical and medical device companies, with $190.96 received in 2019. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($290.41).
As a Medicare-enrolled provider, Kanhere has provided services to 6,159 Medicare beneficiaries, totaling 12,249 services with total Medicare billing of $362,899. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Dallas, TX
- Active Since 05/10/2007
- Last Updated 02/04/2015
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1386858140
Products in Payments
- TAGRISSO (Drug) $104.83
- KEYTRUDA (Biological) $99.45
- IMFINZI (Drug) $86.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Dallas
Dr. Olga Weinberg, M.d, M.D
Anatomic Pathology — Payments: $54,995
Dr. Kirthi Kumar, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $7,027
Richard Hopley, Md, MD
Anatomic Pathology — Payments: $5,797
Xin Zhou, Md, MD
Anatomic Pathology — Payments: $2,611
Elizabeth Dole, M.d, M.D
Anatomic Pathology — Payments: $779.72
Donna Lager, M.d, M.D
Anatomic Pathology — Payments: $581.91